1 / 10

Hepatitis C for the General Practitioner

Learn why and how to test for hepatitis C, who should be tested, testing methods, and treatment considerations. Understand the link between hepatitis C and liver cancer.

fiorenza
Télécharger la présentation

Hepatitis C for the General Practitioner

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013

  2. Testing for hepatitis C • Why should patients be tested? • Who should be tested? • What tests to do

  3. Why test for hepatitis C • Hepatitis C is common • Prevalence between 0.8-1% • 272,000-340,000 people in Canada • All patients with hepatitis C will develop progressive liver disease • Rate of progression is variable • Some will never develop cirrhosis • This is unpredictable • Hepatitis C is curable • Current therapy will cure 65-75% • Future therapy will cure > 90%

  4. Who should be tested for hepatitis C • Test patients who fall into recognized at-risk groups • Anyone who ever used injection drugs, even once, and even if it was many years ago • History of incarceration • Tattoos in an unlicensed parlour • Anyone transfused before 1990 • Immigrants from countries where hepatitis C is highly prevalent • Italy • Egypt • Somalia • Japan • All Eastern European countries • Vietnam

  5. Who to test for hepatitis C • However, risk-based testing not very effective • Risk factors often not recognized • Canadian Liver Foundation recommends testing all adults born between 1945 and 1975. • Accounts for more than 80% of all hepatitis C in Canada • Includes most previous injection drug users • Includes most at-risk adult immigrants

  6. How to test for hepatitis C • Anti-HCV • Indicates exposure • Does not confirm current infection • About 20-30% will clear virus but remain antibody-positive • If positive this has to be followed by • HCV RNA and HCV genotype • Positive HCV RNA confirms active infection • Genotype and viral load are important to decide on treatment strategy • Liver blood tests

  7. Liver blood tests • These are tests that should be done in patients with hepatitis C to assess liver disease • ALT • Marker of hepatic inflammation • A normal ALT does not exclude significant liver disease • Bilirubin, albumin, INR • These are tests of liver function • Any abnormal tests requires further investigation • CBC • A low platelet count raises the possibility of cirrhosis • Ultrasound

  8. Indicators of possible cirrhosis • AST > ALT • Elevated ALP with no other explanation • Low platelets • Low white cell count • (excluding constitutional low levels in people of African descent) • Ultrasound findings of • Coarse echotexture of the liver (assuming no fatty infiltration) • Splenomegaly • Nodular liver

  9. Who should be treated for hepatitis C • Treatment decision takes many variables into account • Patient wishes • Likelihood of response • Urgency or lack of urgency for treatment • Severity of liver disease • All patients should be evaluated for treatment • Patients with normal or only mildly elevated ALT should also be assessed for treatment • Some will have advanced fibrosis or cirrhosis

  10. Hepatitis C and Liver Cancer • There is an increased risk of liver cancer in patients with hepatitis C • The risk is largely limited to patients with cirrhosis • Late stage fibrosis also has an increased risk, although not as high as with cirrhosis • Patients at high risk should undergo HCC screening with ultrasound once every 6 months

More Related